Bluesky Facebook Reddit Email

Novel immunotherapy mechanism suppresses breast cancer development

06.03.22 | Massachusetts General Hospital

Creality K1 Max 3D Printer

Creality K1 Max 3D Printer rapidly prototypes brackets, adapters, and fixtures for instruments and classroom demonstrations at large build volume.


Journal of Experimental Medicine

10.1084/jem.20201963

Experimental study

Animals

CD4+ T helper 2 cells suppress breast cancer by inducing terminal differentiation

3-Jun-2022

Disclosures: M. Boieri is an employee of Zelluna Immunotherapy. S. Iyer is an employee of and has equity in Verve Therapeutics. M.N. Rivera reported grants from Advanced Cell Diagnostics and non-financial support from Merck/Serono outside the submitted work. No other disclosures were reported.

Keywords

Article Information

Contact Information

Katie Marquedant
Massachusetts General Hospital
KMarquedant@partners.org

How to Cite This Article

APA:
Massachusetts General Hospital. (2022, June 3). Novel immunotherapy mechanism suppresses breast cancer development. Brightsurf News. https://www.brightsurf.com/news/LN2XRNY1/novel-immunotherapy-mechanism-suppresses-breast-cancer-development.html
MLA:
"Novel immunotherapy mechanism suppresses breast cancer development." Brightsurf News, Jun. 3 2022, https://www.brightsurf.com/news/LN2XRNY1/novel-immunotherapy-mechanism-suppresses-breast-cancer-development.html.